Logo

Heat Biologics Signs a Research License Agreement with ProBioGen for Transposase System and Suspension HEK293 Cell Line

Share this
Heat Biologics Signs a Research License Agreement with ProBioGen for Transposase System and Suspension HEK293 Cell Line

Heat Biologics Signs a Research License Agreement with ProBioGen for Transposase System and Suspension HEK293 Cell Line

Shots:

  • ProBioGen collaborates with Heat Biologics for both ProBioGen's DirectedLuck Transposase System along with suspension HEK293 cell line
  • The DirectedLuck Transposase is well-matched with additional genetic elements in standard expression vector design and can be used with any host cell line
  • ProBioGen's HEK293 has been developed for the manufacture of proteins and viral vectors and is distinguished through robust growths in a chemically defined medium in suspension culture to make it a valuable tool for production in large bioreactors

  Ref: ProBioGen | Image: ProBioGen

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions